News
Osurnia Ear Gel for Dogs Sees SPC Update UK Gov Change to the information provided on adverse events in the Summary of Product Characteristics for Osurnia Ear Gel for Dogs. Following monitoring of ...
Reuters — Elanco Animal Health has decided against acquiring Bayer’s Canadian distribution rights to several poultry insecticides, Canada’s Competition Bureau said on Tuesday, as it looks to complete ...
European Pharmaceuticals revenue growth was 5 percent on a reported basis and 8% at constant rates, including the contribution from newly acquired Tri-Solfen ANZ and Osurnia.
Amortisation of acquired intangibles crept up by 8 per cent to £75.2m, largely attributable to new charges relating to the Osurnia and Mirataz acquisitions. The £106.5m deal to acquire the worldwide ...
Dechra Veterinary Products has launched a two-tube pack of Osurnia, its gel treatment for otitis externa. Until now, the treatment has only been available in 20 and 40 pack sizes. The new two-tube ...
The agreement stipulates that Elanco will sell its Canadian Osurnia and Canadian Profender businesses that it will acquire from Bayer with the purchase, according to a news release.
Veterinary pharmaceuticals business Dechra has completed a £104.7m takeover. The listed company has bought the worldwide rights to the Osurnia product portfolio from Elanco Animal Health. Osurnia is a ...
Further to the announcement on 6 January 2020, Dechra is pleased to announce that the acquisition of the worldwide rights of the Osurnia product portfolio (Osurnia) from Elanco Animal Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results